Other News To Note

 ImmunoGenes AG, of Zug, Switzerland, reported the incorporation of ImmunoGenes-ABS Zrt in Gödöllő, Hungary, as a fully owned subsidiary that will formalize the development and production of monoclonal and polyclonal antibodies for a commercial program called Customized Antibody Solutions.